The Seventh man to be cure of HIV from stem cells transplant.

 The recent case involved a 51-year-old man living with HIV who also developed leukemia. In 2015, he underwent a stem cell transplant to replace his diseased immune system with donor cells. Ideally, doctors would have used CCR5-resistant stem cells, but none were available. Instead, the donor cells had one normal and one mutated copy of the CCR5 gene.

After chemotherapy eliminated most of his immune cells, the donor stem cells repopulated his immune system. At first, he continued taking standard antiretroviral therapy. Three years later, confident that the transplant had successfully established a healthy immune system, he decided to stop ART.

Remarkably, extensive blood tests revealed no trace of HIV. Seven years later, he remains virus-free. This makes him the second person cured of HIV using non-resistant stem cells and the seventh person overall to achieve a functional cure.

How Could This Cure Work Without Resistant Cells?

The case challenges the long-held belief that CCR5-resistant stem cells are required to eliminate HIV. Researchers propose that the cure may have been achieved through a combination of factors:

Chemotherapy-Driven Clearance: The chemotherapy regimen likely destroyed most of the patient’s immune cells, including those infected with HIV. This drastically reduced the virus’s reservoir in the body.

Donor-Recipient Immune Interactions: The new donor cells may have recognized the patient’s remaining immune cells as foreign and eliminated them. This immune reaction could prevent HIV from finding cells to infect, effectively stopping viral replication.

Partial CCR5 Mutation: While the donor cells were not fully resistant, the presence of one CCR5 mutation might have altered immune cell behavior in a way that reduced HIV’s ability to spread.

This combination of factors suggests that achieving a cure may not require fully resistant stem cells, widening the pool of potential donors. However, experts caution that this procedure is complex, risky, and only suitable for patients who already need a stem cell transplant for a life-threatening condition like cancer.

Implications for HIV Research

This case offers several important lessons for researchers and clinicians:

Stem Cell Therapy Potential: More people with HIV may be eligible for experimental cure strategies using stem cells, even if the cells are not genetically resistant to the virus.

Understanding Immune Mechanisms: The patient’s recovery highlights the role of the immune system in eliminating residual infected cells. This insight could guide future therapies, including gene editing and immunotherapy.

Need for Safe Alternatives: Stem cell transplants are dangerous and not suitable for healthy individuals with HIV. Safer approaches, such as gene therapy or long-acting antiretroviral injections, remain the most practical options for the broader population.

ART Remains Essential

Although this case is groundbreaking, antiretroviral therapy remains the standard of care for people living with HIV. Daily or long-acting ART effectively suppresses viral replication, prevents transmission, and allows individuals to live healthy, long lives.

Newer medications, such as injectable therapies given only a few times per year, offer even more convenience while maintaining viral suppression. These treatments remain far safer and more accessible than experimental stem cell transplants.

Looking Ahead: Toward a Cure

Researchers are exploring additional strategies for curing HIV, including:

Gene Editing: Techniques like CRISPR could modify a patient’s own immune cells to resist HIV infection. Early studies show promise in lab experiments and small clinical trials.

Therapeutic Vaccines: Scientists are investigating vaccines that train the immune system to recognize and eliminate HIV-infected cells, potentially reducing viral reservoirs.

Combination Therapies: Future cures may involve a combination of stem cell therapy, immune modulation, and gene editing to achieve long-term remission.

Although these approaches are still experimental, the recent success demonstrates that a functional cure is possible, even without fully resistant stem cells. This offers renewed hope for millions of people living with HIV worldwide.

Key Takeaways

A man with HIV has been cured through a stem cell transplant using non-resistant cells.

Previous HIV cures relied on stem cells with the CCR5 mutation, but this case shows they may not be strictly necessary.

The cure likely resulted from a combination of chemotherapy, donor immune responses, and partial CCR5 mutation.

Stem cell transplants are risky and only suitable for patients with serious blood disorders.

Antiretroviral therapy remains the safest and most effective treatment for most people with HIV.

Emerging therapies like gene editing and therapeutic vaccines could expand cure options in the future.

Conclusion

This extraordinary case challenges decades of assumptions about HIV treatment and cures. It suggests that under certain conditions, the human immune system can eliminate HIV, even without genetically resistant donor cells. While stem cell transplants are not a practical solution for the broader population, this discovery inspires optimism for innovative therapies that may one day provide a cure accessible to millions.

For now, continued research, adherence to antiretroviral therapy, and advancements in gene therapy and immune-based treatments remain critical. This case is a reminder that scientific progress often comes in unexpected ways, reshaping our understanding of what is possible.